Keyphrases
Non-responders
100%
CD8+ T Cell Infiltration
100%
Stereotactic Radiotherapy
100%
Immune Checkpoint Inhibitors
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Navigational Bronchoscopy
100%
Quality of Life Assessment
100%
Factors Predicting
100%
Quality of Life
100%
Headband
100%
Factor Analysis
100%
Single-sided Deafness
100%
Auricular Prosthesis
100%
Bone Conduction Device
100%
Long-term Quality of Life
100%
Prosthesis
75%
Skin Reactions
75%
CD8+ T Cells
60%
Solitary Pulmonary Nodule
60%
Holgers
50%
In Vitro Activation
40%
Median Progression-free Survival
40%
Immune Checkpoint Inhibitor Treatment
40%
Staphylococcal Enterotoxins
40%
Interleukin-2
40%
Circulating T Cells
40%
Trunk mutations
25%
NCI-CTCAE
25%
Short Form-12
25%
Medical Outcomes Study
25%
Hygiene
25%
Prosthesis Replacement
25%
Rosenberg Self-esteem Scale
25%
Question Form
25%
Self-esteem
25%
Redness
25%
General Patients
25%
Quality of Life Improvement
25%
Retrospective Case Series
25%
Glasgow Benefit Inventory
25%
Peri-implant
25%
CD4+
20%
Treatment Response
20%
Healthy Controls
20%
Robust Biomarker
20%
Potential Biomarkers
20%
IL-2 Receptor
20%
Response Predictors
20%
Luminex
20%
T Cell Activation Markers
20%
Medicine and Dentistry
Stereotactic Radiotherapy
100%
Lung Nodule
100%
Non Small Cell Lung Cancer
100%
Diagnosis
100%
Ticilimumab
100%
Primary Tumor
100%
Durvalumab
100%
Bronchoscopy
100%
Quality of Life Assessment
100%
Bone Conduction
100%
Prosthesis
100%
Hearing Impairment
100%
Quality of Life
83%
Immunotherapy
80%
Adverse Event
56%
Skin Manifestation
50%
Implant
50%
Stereotactic Body Radiation Therapy
40%
Invasive Procedure
33%
Rosenberg Self-Esteem Scale
33%
Radiation Therapy
20%
Monotherapy
20%
Colitis
20%
Breathing
20%
Malignant Neoplasm
16%
Transthoracic Biopsy
16%
Cohort Study
16%
Patient Population
16%
Puncture
16%
Short Form 12
16%
Prosthetic Replacement
16%
Contralateral
15%
Disability
5%
Case-Control Study
5%
Air Conduction
5%
Immunology and Microbiology
T Cell Activation
100%
Cytotoxic T-Cell
100%
Immunotherapy
100%
Durvalumab
100%
Tremelimumab
100%
Enterotoxin
40%
T Cell
40%
CD69
40%
Cytokine
40%
Progression Free Survival
40%
Trunk
25%
Breathing
25%
Neoantigen
25%
Tumor Volume
25%
Colitis
25%
Cytokine Production
20%
Lymphocyte
20%
Blood Level
20%
Immunocompetent Cell
20%
IL-2 Receptor
20%
Tumor Necrosis Factor
20%
B Cell Activating Factor
20%
T-Helper Cell
20%